LIGAND PHARMACEUTICALS INC - COM NEW (LGND)

Q4 2018 13F Holders as of 12/31/2018

Type / Class
Equity / COM NEW
Number of holders
355
Total Shares
26.8M
Shares change
+2.46M
Total reported value, excl. options
$3.63B
Value change
+$252M
Put/Call ratio
1.93
Number of buys
198
Number of sells
-169
Price
$135.70
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.